AIM ImmunoTech Inc.AIM ImmunoTech Inc.AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

No trades
See on Supercharts
Market capitalization
‪23.20 M‬USD
‪−28.96 M‬USD
‪202.00 K‬USD
‪45.32 M‬
Beta (1Y)

About AIM ImmunoTech Inc.

Thomas Kenwood Equels
Employees (FY)
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AIM is 0.4650 USD — it has decreased by 2.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange AIM ImmunoTech Inc. stocks are traded under the ticker AIM.
AIM ImmunoTech Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
AIM stock is 7.44% volatile and has beta coefficient of 1.77. Check out the list of the most volatile stocks — is AIM ImmunoTech Inc. there?
One year price forecast for AIM ImmunoTech Inc. has a max estimate of 2.0000 USD and a min estimate of 2.0000 USD.
AIM earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.11 USD resulting in a −41.18% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about AIM ImmunoTech Inc. earnings.
AIM ImmunoTech Inc. revenue for the last quarter amounts to ‪46.00 K‬ USD despite the estimated figure of ‪24.00 K‬ USD. In the next quarter revenue is expected to reach ‪36.50 K‬ USD.
Yes, you can track AIM ImmunoTech Inc. financials in yearly and quarterly reports right on TradingView.
AIM stock has fallen by 22.32% compared to the previous week, the month change is a 16.25% rise, over the last year AIM ImmunoTech Inc. has showed a 15.24% decrease.
AIM net income for the last quarter is ‪−12.58 M‬ USD, while the quarter before that showed ‪−7.82 M‬ USD of net income which accounts for −60.90% change. Track more AIM ImmunoTech Inc. financial stats to get the full picture.
Today AIM ImmunoTech Inc. has the market capitalization of ‪23.20 M‬, it has increased by 8.62% over the last week.
No, AIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM ImmunoTech Inc. stock right from TradingView charts — choose your broker and connect to your account.
AIM reached its all-time high on Mar 2, 2000 with the price of 10036.0128 USD, and its all-time low was 0.2910 USD and was reached on Dec 30, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 22, 2024, the company has 26.00 employees. See our rating of the largest employees — is AIM ImmunoTech Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIM ImmunoTech Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIM ImmunoTech Inc. stock shows the sell signal. See more of AIM ImmunoTech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on AIM ImmunoTech Inc. future price: according to them, AIM price has a max estimate of 2.00 USD and a min estimate of 2.00 USD. Read a more detailed AIM ImmunoTech Inc. forecast: see what analysts think of AIM ImmunoTech Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AIM ImmunoTech Inc. EBITDA is ‪−31.62 M‬ USD, and current EBITDA margin is ‪−15.68 K‬%. See more stats in AIM ImmunoTech Inc. financial statements.